The project aims to develop the first wearable closed-loop drug delivery device (DDD) that uses tonoarteriography as real-time feedback for hypertension monitoring and drug delivery. It delivers drugs automatically based on continuous arterial blood pressure powered by an intelligent drug decision-making algorithm to determine optimal dosage. The DDD achieved by iontophoresisand chemical penetration enhancement increases delivery efficiency and accuracy. A wireless module connected to a mobile device allows remote feedback control by clinicians. Our device will bring precise and remote medicine to reality, improving clinical outcomes for millions of hypertensive patients and reduce pressure on the overburdened public healthcare system.
Miss Xiang Ting* (PhD student, Department of Biomedical Engineering, City University of Hong Kong)
Mr Bangul Khan (PhD student, Department of Biomedical Engineering, City University of Hong Kong)
Mr Lau Ho-yeung (Imperial College London)
Dr Ji Nan (Alumna , Department of Biomedical Engineering, City University of Hong Kong)
* Person-in-charge
(Info based on the team's application form)
- CityU HK Tech 300 Seed Fund (2023)
- HKSTP IDEATION Programme (2023)
- Third Place, 2022 EMBS Best Paper Award, IEEE Engineering in Medicine and Biology Society
- Silver Award, 2022 COCHE Outstanding Scholars in Cardiovascular Engineering (OS-CARE) Awards, Hong Kong Centre for Cerebro-Cardiovascular Health Engineering
- Gold Award, 2021 COCHE Outstanding Scholars in Cardiovascular Engineering (OS-CARE) Awards, Hong Kong Centre for Cerebro-Cardiovascular Health Engineering